CC2D1B

CC2D1B (Freud-2/Lgd1) is a multifunctional scaffold protein that operates in both nuclear transcriptional repression and ESCRT-III-dependent membrane remodeling (PMID:19423080, PMID:30513301). In the nucleus it binds the dual repressor element (DRE) of the serotonin-1A (5-HT1A) receptor gene promoter, at a site adjacent to that bound by its paralog CC2D1A/Freud-1, and represses 5-HT1A receptor transcription; depletion de-represses promoter activity and raises receptor protein levels in neuronal cells (PMID:19423080, PMID:21155902). At cellular membranes CC2D1B coordinates ESCRT-III activity: during mitotic nuclear envelope reformation it regulates the spatiotemporal distribution of the CHMP7-ESCRT-III axis and couples ESCRT activity to Spastin-mediated spindle microtubule severing, and on endosomes it restrains premature sorting of transmembrane receptors EGFR and TLR4 into intraluminal vesicles, thereby sustaining downstream ERK1/2 signaling, acting alongside CC2D1A which binds CHMP4B polymers (PMID:30513301, PMID:27769858). CC2D1B cycles between cytosol and endosomal membranes in a VPS4-sensitive manner and can functionally substitute for the Drosophila ortholog Lgd, indicating conserved ESCRT-III-related function (PMID:26720614). In the nervous system CC2D1B is required for normal CNS developmental myelination, with constitutive knockout mice showing selective hypomyelination of large-diameter optic nerve fibers (PMID:35592111). It physically interacts with CC2D1A in the brain while occupying distinct synaptic compartments [PMID:bio_10.1101_2025.06.26.661826].

1. 2009 High

   Established CC2D1B as a sequence-specific transcriptional repressor, answering whether the Freud-1 paralog also controls 5-HT1A receptor gene expression.

   Evidence EMSA, reporter assays, and siRNA knockdown with Western blot in human SK-N-SH cells

   PMID:19423080

   Open questions at the time

   • Did not define co-repressor partners or chromatin-modifying machinery recruited to the DRE
   • Did not resolve how nuclear versus cytoplasmic functions are partitioned
2. 2010 High

   Confirmed conserved, DRE-dependent repression across species and distinguished CC2D1B-DRE complexes from CC2D1A-DRE complexes, clarifying that the two paralogs bind adjacent overlapping sites.

   Evidence EMSA/supershift, reporter assay, ChIP, and siRNA knockdown in neuronal cells (mouse/rat sequences)

   PMID:21155902

   Open questions at the time

   • Functional consequence of adjacent CC2D1A/CC2D1B binding (cooperation vs redundancy) not resolved
   • In vivo transcriptional role in serotonergic circuits not tested
3. 2015 Medium

   Placed CC2D1B in the ESCRT-III pathway and tested its individual requirement for endosomal morphogenesis, showing it cycles to endosomes but is dispensable for endosome size unlike CC2D1A.

   Evidence Conditional knockout mice, EM of endosomes, VPS4 dominant-negative localization, and Drosophila Lgd rescue assay

   PMID:26720614

   Open questions at the time

   • CC2D1B-specific endosomal phenotype was negative, leaving its non-redundant membrane role undefined
   • Mechanism of cytosol-to-membrane cycling not characterized
4. 2016 Medium

   Defined a functional output for CC2D1A/B at endosomes — restraining premature receptor sorting to ILVs — linking the scaffold to receptor signaling duration.

   Evidence siRNA knockdown with EGFR/TLR4 degradation and ERK1/2 signaling assays plus CC2D1A-CHMP4B pulldown

   PMID:27769858

   Open questions at the time

   • CC2D1B contribution reported jointly with CC2D1A without full separation
   • Direct CC2D1B-CHMP4B binding not demonstrated independently of CC2D1A
5. 2018 High

   Identified a distinct membrane-remodeling role in mitosis, showing CC2D1B coordinates the CHMP7-ESCRT-III axis with Spastin-mediated microtubule severing during nuclear envelope reformation.

   Evidence siRNA depletion with live imaging, immunofluorescence, and readouts of nuclear compartmentalization and microtubule dynamics in human cells

   PMID:30513301

   Open questions at the time

   • Direct biochemical interactions of CC2D1B with CHMP7 or Spastin not mapped
   • How CC2D1B times ESCRT recruitment relative to ER deposition not mechanistically resolved
6. 2019 Medium

   Connected CC2D1B to glial myelination, placing it downstream of YAP/TAZ in Schwann cells.

   Evidence YAP/TAZ ablation expression analysis and siRNA silencing with myelin segment quantification in vitro

   PMID:31379499

   Open questions at the time

   • In vitro only; in vivo PNS requirement not established here
   • Molecular link between CC2D1B and myelin gene programs unknown
7. 2022 Medium

   Resolved the in vivo myelination role, showing a selective CNS requirement (optic nerve large-fiber hypomyelination) rather than a general PNS or oligodendrocyte defect.

   Evidence Constitutive Cc2d1b knockout mouse with quantitative EM g-ratio analysis and immunohistology

   PMID:35592111

   Open questions at the time

   • Cell-autonomous mechanism in oligodendrocytes vs axons not determined
   • Relationship between myelination role and ESCRT/transcriptional functions unknown
8. 2025 Low

   Tested the paralog relationship in brain, showing CC2D1A and CC2D1B physically interact yet occupy distinct synaptic compartments.

   Evidence Co-immunoprecipitation and synaptic fractionation in mouse hippocampus (preprint)

   PMID:bio_10.1101_2025.06.26.661826

   Open questions at the time

   • Preprint, single lab; reciprocal validation and CC2D1B-specific synaptic function not established
   • Functional consequence of heterotypic CC2D1A/B interaction unknown

• It remains unknown how CC2D1B's distinct activities — DRE-bound transcriptional repression, ESCRT-III coordination at the nuclear envelope and endosomes, and CNS myelination — are integrated within a single protein and partitioned across subcellular compartments.
• No structural basis for substrate/partner selection across functions
• No direct CC2D1B-CHMP4B/CHMP7 binding map separate from CC2D1A
• No defined disease-causing CC2D1B mutation in the corpus